Artículos de revistas
Ki-67 and CD100 immunohistochemical expression is associated with local recurrence and poor prognosis in soft tissue sarcomas, respectively
Fecha
2013-10-01Registro en:
Oncology Letters, v. 5, n. 5, p. 1527-1535, 2013.
1792-1074
1792-1082
10.3892/ol.2013.1226
WOS:000318385500017
2-s2.0-84875711548
2-s2.0-84875711548.pdf
0717563036484228
0409192855702608
Autor
Pio XII Foundation
Universidade Estadual Paulista (Unesp)
Universidade de São Paulo (USP)
University of Minho
Institución
Resumen
Soft tissue sarcomas (STSs) are a heterogeneous group of mesenchymal tumors of >50 subtypes. However, STSs represent <1% of types of cancer. Despite this low frequency, the disease is aggressive and treatment, when possible, is based on traditional chemotherapies. A number of cases of resistance to adjuvant therapies have been reported. Metastases are commonly identified in STS patients during diagnosis and the development of effective clinical parameters is crucial for correct management of the disease. The use of biological markers in cancer is a useful tool to determine patient prognosis. Ki--67 is a protein marker for proliferation of somatic cells and is widely used in prognostic studies of various types of tumor, including STSs. Cluster of differentiation 100 (CD100) is a member of the semaphorin family. The family was initially described as axon guidance molecules important for angiogenesis, organogenesis, apoptosis and neoplasia. CD100 was previously utilized as a prognostic factor in tumors and also in STSs. In the present study, protein expression of Ki--67 and CD100 was analyzed by immunohistochemistry in samples of STS patients of the Barretos Cancer Hospital (Barretos, Brazil) to establish prognostic criteria of the disease. Results demonstrate a correlation between CD100 expression and poor prognosis, consistent with a previous study. Moreover, the expression of Ki-67 was identified to correlate with presence of local or locoregional recurrence. To the best of our knowledge, no large casuistic study has revealed this correlation between Ki--67 and local recurrence in STSs. The use of Ki--67 and CD100 as markers in clinical pathological analysis may be suitable as a prognostic criterion in disease progression.
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
CHARACTERIZATION OF CHILDHOOD CANCER IN BRAZIL FROM THE HOSPITAL-BASED CANCER REGISTRIE, 2000-2016
Nando Nóbrega de Lucena, Nyellisonn; Cristina Leite Damascena, Lecidamia; dos Santos Camêlo Moreira, Mayara; Medeiros Araújo Lima-Filho, Luiz; Gondim Valença, Ana Maria -
Evaluación de la actividad citotóxica de annona squamosa, petiveria alliacea y punica granatum contra las líneas celulares MDA-MB231 de cáncer de seno, SIHA de cáncer de cuello uterino, HT29 de cáncer de colon, A549 de cáncer de pulmón, y PC3 de cáncer de próstata
Gil Carrillo, Mónica EstefaníaDurante los últimos años, el cáncer ha sido uno de los mayores problemas de salud pública en la población a nivel mundial. En el caso de Colombia, la Organización Mundial de la Salud (OMS) ha reportado que los tipos ...